Not applicableLooking for participantsNCT06674811What this trial is testingBiomarkers of Resiliency In Childhood Cancer SurgeryWho this might be right forPediatric CancerNeuroblastomaSarcoma+10 more Mayo Clinic 40
Testing effectiveness (Phase 2)Looking for participantsNCT05039632What this trial is testingPhase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+1 more M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT01217411What this trial is testingRO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerWho this might be right forAdult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more National Cancer Institute (NCI) 5
Early research (Phase 1)Looking for participantsNCT04282044What this trial is testingStudy of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesWho this might be right forSolid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more BioEclipse Therapeutics 60
Not applicableStudy completedNCT03293433What this trial is testingQuantification of microRNAs in Diagnosis of Pulmonary NodulesWho this might be right forPulmonary Cancer University Hospital, Toulouse 103
Not applicableLooking for participantsNCT06440616What this trial is testingBenefit of Spectral Information in Patients Suspected for Lung CancerWho this might be right forLung Neoplasm Malignant Copenhagen University Hospital at Herlev 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04560686What this trial is testingBintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung CancerWho this might be right forResectable Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+8 more M.D. Anderson Cancer Center 2
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Not applicableLooking for participantsNCT06349642What this trial is testingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformWho this might be right forEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more Mayo Clinic 324
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188What this trial is testingStudy of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationWho this might be right forKRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more Novartis Pharmaceuticals 344
Early research (Phase 1)Study completedNCT05639751What this trial is testingPRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 MutationWho this might be right forAdvanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancers+1 more Prelude Therapeutics Incorporated 135
Early research (Phase 1)Active Not RecruitingNCT03567642What this trial is testingThe Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung CancersWho this might be right forLung Cancer Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT02568449What this trial is testingNintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is RecurrentWho this might be right forRecurrent Pleural Malignant MesotheliomaStage IV Pleural Mesothelioma Barbara Ann Karmanos Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT07286149What this trial is testingA Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)Who this might be right forLung Neoplasm Malignant Merck Sharp & Dohme LLC 140
Not applicableUnknownNCT05067023What this trial is testingEvaluation for Benign and Malignant Pulmonary Ground-glass Nodules Based on MRI Dynamic Contrast Enhanced ImagingWho this might be right forPulmonary Nodules Qianfoshan Hospital 50
Testing effectiveness (Phase 2)WithdrawnNCT01105390What this trial is testingAMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaWho this might be right forAdvanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00101283What this trial is testingPemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural MesotheliomaWho this might be right forMesothelioma Eastern Cooperative Oncology Group 32
Testing effectiveness (Phase 2)Study completedNCT00408460What this trial is testingImatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerWho this might be right forMalignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more University of Washington 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Looking for participantsNCT06566079What this trial is testingStudy of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid TumorsWho this might be right forMalignant MesotheliomaMetastatic Malignant Solid TumorAdvanced Solid Tumor InSilico Medicine Hong Kong Limited 160